SLC6A3 and Parkinson disease: Relatedly, the regional rsFC between the midbrain and the putamen in PD patients and demented patients with Lewy bodies had been shown to correlate positively with the availability of striatal dopamine transporters [26], suggesting that individual differences in the availability of dopamine transporters may moderate the effects of dopamine pharmacology on rsFC.